Intercontinental Exchange (ICE) insider buying and selling
Every Table I transaction reported by directors and officers of S&P 500 companies on SEC Form 4 filings (2 business days to file): each row labeled with its official transaction code, nothing filtered out beforehand.
Open-market purchases (code P) are the rare signal, in green; sales (code S) are common and often pre-scheduled (10b5-1). Table II (derivatives) is not included: its prices are exercise prices, not market values. Guide: insider buying.
| Date | Ticker | Insider | Role | Shares | Price | Amount | % of stake | Type / filing |
|---|
Download these transactions as CSV No account, no sign-up. The data is public: it comes from SEC Form 4 filings.
Intercontinental Exchange, Inc. (ICE) insider buying and selling: no purchases, 42 sales
144 Form 4 Table I transactions filed with the SEC by Intercontinental Exchange, Inc. insiders between 2025-08-26 and 2026-09-16 (15-month history): 0 open-market purchases and 42 sales, plus 102 transactions under other Form 4 codes, broken down one by one below. The largest open-market trade is a sale of $43.4M by Sprecher Jeffrey C on 2026-02-18.
Intercontinental Exchange insider buying and selling over the last 12 months
Between Oct 21, 2025 and Oct 20, 2026, Intercontinental Exchange insiders filed 35 sales worth $91.3M on the open market, and no purchases.
The biggest seller was Sprecher Jeffrey C (Chief Executive Officer): $66.4M in 2 sales, out of 12 different sellers.
The largest trade of the period was a sale of $43.4M on Feb 18, 2026, by Sprecher Jeffrey C (Chief Executive Officer), under a 10b5-1 plan. Form 4 on sec.gov (0001193125-26-059907).
Of the 35 sales, 34 (97%, $90.2M) carry the 10b5-1 plan flag on the Form 4, meaning they were scheduled months ahead; the other one does not.
The last three months show 10 sales, against 7 in the three before. The latest sale from Sep 14, 2026.
Against its sector (Financial Services, 70 companies with an insider page on this site), over the same dates the median is 10 sales and 0 purchases on the open market. Intercontinental Exchange has more sales than 61 of the other 69, ranks 9 of 70 by net dollars sold, and 32 of the 70 have at least one purchase.
The 20 most important trades
With no open-market purchases, the table starts with ICE's sales, largest first. The full history is in the tool above, already searched.
See all 144 ICE trades in the full history →
| Trade date | Filed | Insider | Role | Amount | Code | Filing |
|---|---|---|---|---|---|---|
| 2026-02-18 | 2026-02-19 | Sprecher Jeffrey C | Chief Executive Officer | $43.4M | S — Open-market sale (scheduled 10b5-1) Indirect holding, through: CPEX 5 Form 4 footnotesF2 This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of May 30, 2025. F3 The common stock number referred in Table I is an aggregate number and represents 1,034,643 shares of common stock and 46,016 unvested restricted stock units ("RSUs"), and 14,264 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year. F4 The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. F5 The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. F6 As previously reported, the reporting person also indirectly owns 1,651,705 shares that are beneficially owned directly by CPEX. The reporting person beneficially owns 100% of the equity interest in CPEX. Additionally, as previously reported, the reporting person indirectly owns shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership. | SEC |
| 2025-11-19 | 2025-11-21 | Sprecher Jeffrey C | Chief Executive Officer | $23.0M | S — Open-market sale (scheduled 10b5-1) Indirect holding, through: CPEX 4 Form 4 footnotesF5 This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of May 30, 2025. F6 The price range for the aggregate amount sold by the direct holder is $152.00 - $152.99. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F7 The price range for the aggregate amount sold by the direct holder is $153.00 - $153.65. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F8 As previously reported, the reporting person also indirectly owns 1,801,705 shares that are beneficially owned directly by CPEX. The reporting person beneficially owns 100% of the equity interest in CPEX. Additionally, as previously reported, the reporting person indirectly owns shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership. | SEC |
| 2026-02-18 | 2026-02-19 | Kapani Mayur | Chief Technology Officer | $2.4M | S — Open-market sale (scheduled 10b5-1)6 Form 4 footnotesF2 This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 6, 2025. F3 The price range for the aggregate amount sold by the direct holder is $153.89 - $154.88. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F4 The price range for the aggregate amount sold by the direct holder is $154.89 - $155.84. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F5 The common stock number referred in Table I is an aggregate number and represents 53,660 shares of common stock and 8,907 unvested restricted stock units ("RSUs"), and 2,302 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year. F6 The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. F7 The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. | SEC |
| 2026-07-16 | 2026-07-20 | Martin Lynn C | President, NYSE Group | $2.2M | S — Open-market sale (scheduled 10b5-1)8 Form 4 footnotesF1 This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of May 29, 2025. F3 The price range for the aggregate amount sold by the direct holder is $139.23 - $140.18. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F4 The price range for the aggregate amount sold by the direct holder is $140.26 - $141.23. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F5 The price range for the aggregate amount sold by the direct holder is $141.27 - $142.22. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F6 The price range for the aggregate amount sold by the direct holder is $142.30 - $142.31. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F7 The common stock number referred in Table I is an aggregate number and represents 41,499 shares of common stock and 9,805 unvested restricted stock units ("RSUs"), and 3,116 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year. F8 The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. F9 The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. | SEC |
| 2026-02-10 | 2026-02-12 | Jackson Benjamin | President | $2.1M | S — Open-market sale (scheduled 10b5-1)2 Form 4 footnotesF1 This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 3, 2025. F2 The price range for the aggregate amount sold by the direct holder is $165.00 - $165.06. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. | SEC |
| 2026-02-20 | 2026-02-24 | Martin Lynn C | President, NYSE Group | $2.1M | S — Open-market sale (scheduled 10b5-1)7 Form 4 footnotesF1 This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of May 29, 2025. F2 The price range for the aggregate amount sold by the direct holder is $152.48 - $153.45. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F3 The price range for the aggregate amount sold by the direct holder is $153.52 - $154.51. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F4 The price range for the aggregate amount sold by the direct holder is $154.52 - $155.25. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F5 The common stock number referred in Table I is an aggregate number and represents 41,398 shares of common stock and 9,805 unvested restricted stock units ("RSUs"), and 3,116 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year. F6 The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. F7 The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. | SEC |
| 2026-09-01 | 2026-09-03 | Jackson Benjamin | President | $2.1M | S — Open-market sale (scheduled 10b5-1)7 Form 4 footnotesF1 This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 3, 2025. F3 The price range for the aggregate amount sold by the direct holder is $158.80 - $159.78. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F4 The price range for the aggregate amount sold by the direct holder is $159.80 - $160.59. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F5 The price range for the aggregate amount sold by the direct holder is $160.89 - $161.29. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F6 The common stock number referred in Table I is an aggregate number and represents 142,265 shares of common stock and 17,204 unvested restricted stock units ("RSUs"), and 4,795 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year. F7 The satisfaction of the 2024, 2025 and 2026 three-year total shareholder return (TSR) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 year-three earnings before interest, taxes, depreciation, and amortization (EBITDA) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. F8 The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. | SEC |
| 2026-02-19 | 2026-02-20 | Edmonds Christopher Scott | President, Fixed Income & Data | $1.7M | S — Open-market sale (scheduled 10b5-1)8 Form 4 footnotesF1 This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of February 20, 2025. F2 The price range for the aggregate amount sold by the direct holder is $152.58 - $153.56. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F3 The price range for the aggregate amount sold by the direct holder is $153.58 - $154.57. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F4 The price range for the aggregate amount sold by the direct holder is $154.58 - $155.25. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F5 The price range for the aggregate amount sold by the direct holder is $155.62 - $155.81. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F6 The common stock number referred in Table I is an aggregate number and represents 2,662 shares of common stock and 9,206 unvested restricted stock units ("RSUs"), and 2,398 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year. F7 The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. F8 The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. | SEC |
| 2025-10-08 | 2025-10-10 | Kapani Mayur | Chief Technology Officer | $1.6M | S — Open-market sale (scheduled 10b5-1)7 Form 4 footnotesF1 This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 6, 2025. F3 The price range for the aggregate amount sold by the direct holder is $156.83 - $157.78. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F4 The price range for the aggregate amount sold by the direct holder is $157.83 - $158.82. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F5 The price range for the aggregate amount sold by the direct holder is $158.84 - $159.53. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F6 The common stock number referred in Table I is an aggregate number and represents 52,317 shares of common stock and 4,487 unvested restricted stock units ("RSUs"), and 8,436 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. F7 The satisfaction of the 2023, 2024 and 2025 three-year total shareholder return (TSR) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2026, February 2027 and February 2028, respectively, and will be reported at the time of vesting. The satisfaction of the 2024 and 2025 three-year earnings before interest, taxes, depreciation, and amortization (EBITDA) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027 and February 2028, respectively, and will be reported at the time of vesting. F8 The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. | SEC |
| 2026-08-05 | 2026-08-07 | Foley Douglas | SVP, HR & Administration | $1.1M | S — Open-market sale4 Form 4 footnotesF1 Amount of securities beneficially owned includes 101 shares acquired under Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2026. F2 The common stock number referred in Table I is an aggregate number and represents 14,632 shares of common stock and 3,472 unvested restricted stock units ("RSUs"), and 959 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year. F3 The satisfaction of the 2024, 2025 and 2026 three-year total shareholder return (TSR) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 year-three earnings before interest, taxes, depreciation, and amortization (EBITDA) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. F4 The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. | SEC |
| 2025-12-08 | 2025-12-10 | Kapani Mayur | Chief Technology Officer | $837k | S — Open-market sale (scheduled 10b5-1)6 Form 4 footnotesF1 This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 6, 2025. F2 The price range for the aggregate amount sold by the direct holder is $155.83 - $156.81. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F3 The price range for the aggregate amount sold by the direct holder is $156.83 - $157.18. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F4 The common stock number referred in Table I is an aggregate number and represents 52,317 shares of common stock and 4,487 unvested restricted stock units ("RSUs"), and 8,436 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. F5 The satisfaction of the 2023, 2024 and 2025 three-year total shareholder return (TSR) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2026, February 2027 and February 2028, respectively, and will be reported at the time of vesting. The satisfaction of the 2024 and 2025 three-year earnings before interest, taxes, depreciation, and amortization (EBITDA) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027 and February 2028, respectively, and will be reported at the time of vesting. F6 The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. | SEC |
| 2026-09-01 | 2026-09-03 | Edmonds Christopher Scott | President, Fixed Income & Data | $803k | S — Open-market sale (scheduled 10b5-1)4 Form 4 footnotesF1 This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of February 6, 2026. F3 The common stock number referred in Table I is an aggregate number and represents 2,763 shares of common stock and 9,206 unvested restricted stock units ("RSUs"), and 2,398 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year. F4 The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. F5 The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. | SEC |
| 2026-02-05 | 2026-02-09 | Sprieser Judith A | Director | $799k | S — Open-market sale (scheduled 10b5-1)7 Form 4 footnotesF1 This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 5, 2025. F2 The price range for the aggregate amount sold by the direct holder is $166.44 - $167.34. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F3 The price range for the aggregate amount sold by the direct holder is $167.69 - $168.66. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F4 The price range for the aggregate amount sold by the direct holder is $168.71 - $169.68. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F5 The price range for the aggregate amount sold by the direct holder is $169.71 - $170.05. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F6 The price range for the aggregate amount sold by the direct holder is $170.97 - $171.61. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F7 The common stock number referred in Table I is an aggregate number and represents 8,273 shares of common stock and 1,474 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 16, 2026. | SEC |
| 2026-02-26 | 2026-03-02 | Surdykowski Andrew J | General Counsel | $741k | S — Open-market sale (scheduled 10b5-1)3 Form 4 footnotesF1 This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 25, 2025. F2 The price range for the aggregate amount sold by the direct holder is $161.37 - $162.22. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F3 The price range for the aggregate amount sold by the direct holder is $162.42 - $162.87. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. | SEC |
| 2026-08-26 | 2026-08-28 | Surdykowski Andrew J | General Counsel | $740k | S — Open-market sale (scheduled 10b5-1)6 Form 4 footnotesF1 This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 25, 2025. F3 The price range for the aggregate amount sold by the direct holder is $161.16 - $162.14. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F4 The price range for the aggregate amount sold by the direct holder is $162.16 - $162.95. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F5 The common stock number referred in Table I is an aggregate number and represents 35,891 shares of common stock and 5,734 unvested restricted stock units ("RSUs"), and 1,440 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year. F6 The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. F7 The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. | SEC |
| 2026-05-26 | 2026-05-28 | Surdykowski Andrew J | General Counsel | $693k | S — Open-market sale (scheduled 10b5-1)6 Form 4 footnotesF1 This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 25, 2025. F2 The price range for the aggregate amount sold by the direct holder is $150.46 - $151.45. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F3 The price range for the aggregate amount sold by the direct holder is $151.95 - $152.00. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F4 The common stock number referred in Table I is an aggregate number and represents 38,299 shares of common stock and 5,734 unvested restricted stock units ("RSUs"), and 1,440 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year. F5 The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. F6 The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. | SEC |
| 2025-08-26 | 2025-08-28 | Surdykowski Andrew J | General Counsel | $687k | S — Open-market sale (scheduled 10b5-1)4 Form 4 footnotesF1 This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 20, 2024. F3 The common stock number referred in Table I is an aggregate number and represents 37,399 shares of common stock, 3,141 unvested restricted stock units ("RSUs"), and 5,753 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year. F4 The satisfaction of the 2023, 2024 and 2025 three-year total shareholder return PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2026, February 2027 and February 2028, respectively, and will be reported at the time of vesting. The satisfaction of the 2024 and 2025 three-year EBITDA PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027 and February 2028, respectively, and will be reported at the time of vesting. F5 The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. | SEC |
| 2026-05-14 | 2026-05-18 | Kapani Mayur | Chief Technology Officer | $664k | S — Open-market sale (scheduled 10b5-1)6 Form 4 footnotesF1 This transaction was effected pursuant to a Rule 10b5-l trading plan which was approved and became effective as of February 12, 2026. F2 The price range for the aggregate amount sold by the direct holder is $154.60 - $155.59. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F3 The price range for the aggregate amount sold by the direct holder is $155.62 - $155.96. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F4 The common stock number referred in Table I is an aggregate number and represents 53,660 shares of common stock, 8,907 unvested restricted stock units ("RSUs"), and 2,302 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year. F5 The satisfaction of the 2024, 2025 and 2026 three-year total shareholder return ("TSR") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. F6 The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. | SEC |
| 2026-08-12 | 2026-08-14 | Kapani Mayur | Chief Technology Officer | $646k | S — Open-market sale (scheduled 10b5-1)6 Form 4 footnotesF1 This transaction was effected pursuant to a Rule 10b5-l trading plan which was approved and became effective as of February 12, 2026. F3 The price range for the aggregate amount sold by the direct holder is $149.55 - $150.25. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F4 The price range for the aggregate amount sold by the direct holder is $150.76 - $151.71. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F5 The common stock number referred in Table I is an aggregate number and represents 56,779 shares of common stock, 8,907 unvested restricted stock units ("RSUs"), and 2,302 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year. F6 The satisfaction of the 2024, 2025 and 2026 three-year total shareholder return ("TSR") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. F7 The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. | SEC |
| 2026-02-27 | 2026-03-03 | Jackson Benjamin | President | $638k | S — Open-market sale (scheduled 10b5-1)4 Form 4 footnotesF1 This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 3, 2025. F2 The common stock number referred in Table I is an aggregate number and represents 139,440 shares of common stock and 17,204 unvested restricted stock units ("RSUs"), and 4,795 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year. F3 The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. F4 The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. | SEC |
The period balance: money in, money out
In the Form 4 filings submitted between Aug 26, 2025 and Sep 16, 2026 there is not one open-market purchase of Intercontinental Exchange, Inc.: 42 sales worth $95.0M and zero dollars bought.
Only codes P and S count, where an insider puts in or takes out their own money. A selling balance like Intercontinental Exchange, Inc.'s is the norm in the S&P 500, where much of the pay comes as stock. It is not a recommendation to buy or sell: it is what was filed.
Every transaction, code by code
| Code | What it means | Trades | Reported amount |
|---|---|---|---|
| F | Tax withholding (shares surrendered for taxes) | 48 | $25.3M |
| S | Open-market sale | 42 | $95.0M |
| A | Grant or award | 33 | $0 |
| M | Option exercise | 16 | $8.7M |
| G | Gift | 5 | $0 |
| Total | Everything filed in the period | 144 | $129.1M |
41 of the 144 rows carry no usable amount on the Form 4: they count as trades and add $0. The code labels come from the SEC index.
Who has traded
Over the 15 months of history, 22 distinct people or entities have filed Intercontinental Exchange, Inc. transactions: none bought on the open market and 14 sold. Counted by CIK, the fixed number the SEC gives each filer, and not by name, which each filer types their own way.
Of the 14 who sold on the open market (42 sales in all), the three biggest sellers account for $77.9M of the $95.0M: 82% of the money in three people.
| Filer | Role | Transactions | Bought (count) | Sold (count) | Last filed |
|---|---|---|---|---|---|
| Sprecher Jeffrey C | Chief Executive Officer | 10 | — | $66.4M (2) | 2026-02-19 |
| Kapani Mayur | Chief Technology Officer | 16 | — | $6.1M (5) | 2026-08-14 |
| Jackson Benjamin | President | 13 | — | $5.4M (4) | 2026-09-03 |
| Martin Lynn C | President, NYSE Group | 12 | — | $4.3M (2) | 2026-07-20 |
| Surdykowski Andrew J | General Counsel | 18 | — | $3.4M (6) | 2026-08-28 |
| Edmonds Christopher Scott | President, Fixed Income & Data | 9 | — | $2.5M (2) | 2026-09-03 |
| Foley Douglas | SVP, HR & Administration | 12 | — | $2.4M (6) | 2026-09-16 |
| Sprieser Judith A | Director | 3 | — | $1.9M (3) | 2026-02-09 |
Shown here are the 8 who moved the most money, out of 22. The rest are in the full history, one link above. The name links to all their trades, in any company. "Transactions" counts any code; the money, open market only. Role: from their latest filing.
Month by month
By the month the trade was executed, not the month it was filed; months with no trades show zero. The busiest month was Feb 2026: 0 purchases and 10 sales, worth $54.8M. 3 of the 15 months have none.
| Month | Purchases | Amount | Sales | Amount |
|---|---|---|---|---|
| Aug 2025 | 0 | $0 | 3 | $1.2M |
| Sep 2025 | 0 | $0 | 3 | $949k |
| Oct 2025 | 0 | $0 | 1 | $1.6M |
| Nov 2025 | 0 | $0 | 4 | $23.8M |
| Dec 2025 | 0 | $0 | 3 | $1.7M |
| Jan 2026 | 0 | $0 | 0 | $0 |
| Feb 2026 | 0 | $0 | 10 | $54.8M |
| Mar 2026 | 0 | $0 | 1 | $264k |
| Apr 2026 | 0 | $0 | 0 | $0 |
| May 2026 | 0 | $0 | 4 | $1.8M |
| Jun 2026 | 0 | $0 | 2 | $199k |
| Jul 2026 | 0 | $0 | 1 | $2.2M |
| Aug 2026 | 0 | $0 | 7 | $3.4M |
| Sep 2026 | 0 | $0 | 3 | $3.1M |
| Oct 2026 | 0 | $0 | 0 | $0 |
The last month may be partial: a Form 4 is filed up to two business days later. The table does not say whether the pattern is good or bad; it says when it happened.
Intercontinental Exchange, Inc. (ICE) analysis page →
Other Financial Services companies with insider trades
All 500 are listed in the section index →
Which insiders are buying their own company stock →
How to read this data
19 of the 20 sales in the table are flagged as scheduled (10b5-1 plan): signed months ahead and executed automatically, so they say nothing about what the insider thinks today. Intercontinental Exchange has no open-market purchase (code P) in the history, the most common case in the S&P 500: insiders are already paid in stock. The latest filing is from Sep 16, 2026, and a Form 4 arrives up to two business days after the trade.
20 of the 20 rows in the table carry footnotes from the Form 4 itself, folded into the code column and copied verbatim; a row with no footnote means the filing has none.
Guide: Insider buying · all guides
What is behind these trades
The concepts on this page, explained from scratch in the Academy. Free, no account.
- What the efficiency hypothesis says and what it does NOT sayIf an insider's purchase is public and anyone can read it, is there any information left in it? That is the exact question that brings people here.
- Who really moves the market: the types of investorWho sits on the other side of each order, and where a company's own insiders fit among them.
- Supply, demand and price: why it rises and falls constantlyHow a piece of news ends up inside the price, and why the reaction to a filed sale is rarely the one you would expect.
Source: SEC EDGAR Form 4. This is a list of public facts, not financial advice or a recommendation to buy or sell.